Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus | NCT07679776 | Trialant
Enrolling by invitationObservationalUpdated Jul 1, 2026
Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus
Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus
ClinicalTrials.gov ID
NCT07679776
Lead Sponsor
The First Affiliated Hospital of Anhui Medical UniversityOTHER
Overall Status
Enrolling by invitation
Study Type
Observational
Enrollment
100Estimated
Last Update Posted
Jul 1, 2026Actual
Start Date
Jan 1, 2025Actual
Primary Completion Date
Dec 31, 2025Actual
Completion Date
Jun 30, 2026Estimated
Official Title
Study on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus
Brief Summary
OCT, OCTA, fundus photography, and fundus autofluorescence ( FAF ) were used to observe the fundus physiological indexes of normal subjects and SLE patients, to explore the differences of subclinical retinal damage in SLE patients with different degrees of disease activity, to summarize the changes of subclinical retina in SLE patients without organic retinopathy, and to evaluate its correlation with disease activity, which is of great significance for improving the prognosis of visual function and improving the quality of life in SLE patients.
By evaluating the visual psychophysical indicators, mainly the visual function test results of different colors and different frequencies, reflecting the functional status of the retina and the degree and characteristics of functional impairment in SLE patients with different degrees of disease activity, in order to screen out the clinical markers of SLE fundus lesions, and provide a reliable reference for the prevention and early intervention of visual impairment.
Systemic Lupus Erythematosus (SLE)
Visual Function
No interventions
There are no interventions for this study.
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
the best corrected visual acuity ( BCVA ) of all cases must be ≥ 1.0 according to the international standard visual acuity char;
intraocular pressure ( IOP ) in the normal range, namely 10 mmHg ≤ IOP ≤ 21 mmHg ;
visual field meter examination center and peripheral visual field without defect ;
no degeneration of fundus retina ;
Exclusion Criteria:
obvious abnormality in cranial MRI ;
history of glaucoma, cataract, retinal vascular disease, retinitis pigmentosa and other eye diseases ;
history of refractive surgery such as corneal refractive surgery and cataract surgery ;
other major disease history or systemic lesions affecting the eye ;
history of disease affecting cognitive function, can understand and cooperate with the examination.
Observational Model
Case-Control
Time Perspective
Cross-Sectional
No central contacts
There are no central contacts for this study.
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Lead Sponsor
The First Affiliated Hospital of Anhui Medical UniversityOTHER